Licensing Revenue Agreement - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Deferred Revenue Arrangement [Line Items]
License revenue recognized		$ 0	$ 0	$ 0	$ 442,000
Deferred revenue		0	0	0	0	$ 0	$ 442,000
Merck Neuromuscular License Agreement
Deferred Revenue Arrangement [Line Items]
License revenue recognized		$ 0	$ 5,000,000	0	$ 5,000,000
Milestone payments	$ 5,000,000
Milestones and royalties on net sales				$ 255,000,000